Moderna chief warns against ‘putting our guard down’ on Covid-19
Moderna on Tuesday reported that its vaccine produced protective antibodies against the delta variant, which is causing concern in the US and many other parts of the world
Moderna on Tuesday reported that its vaccine produced protective antibodies against the delta variant, which is causing concern in the US and many other parts of the world
Moderna Inc.’s chairman vowed to keep testing the drugmaker’s Covid-19 vaccine on variants and advised against “putting our guard down" as mutations emerge.
The new strains stem from “a natural process but it is concerning," Moderna chairman Noubar Afeyan said. “We really don’t know where these variants are going to go."
Moderna on Tuesday reported that its vaccine produced protective antibodies against the delta variant, which is causing concern in the US and many other parts of the world. The stock surged to a record.
One crucial lesson gleaned from the past year and a half is to ensure the world doesn’t slip back into “reactive mode," according to Afeyan.
“We’ve been gaining advantage over this virus -- that really is kind of gunning for our immune system constantly -- by being proactive, by being preventive," he said. “We can’t get to a point where we wait for another sort of variant to really do damage and then start saying ‘now what do we do."
Never miss a story! Stay connected and informed with Mint. Download our App Now!!